Assessment of efficacy of medication combined with WeChat platform for quitting smoking in patients with chronic obstructive pulmonary disease

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 36, Issue 3, 2016, Pages 385-389

  Yang, De Xiang ^a   Gu, Chen Juan ^b   Ni, Lei ^b   Li, Ning ^b   Li, Qing Yun ^b   Zhou, Jian Ping ^b  

^a People's Hospital of Tongling   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic obstructive pulmonary disease patients; Nicotine replacement therapy; Smoking abstinence rate; WeChat follow up

Indexed keywords

VARENICLINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HUMAN; INTERNET; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 84965130020     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1674-8115.2016.03.014     Document Type: Article

References (17)

1. Jha P, Peto R. Global effects of smoking, of quitting, and taxing tobacco[J]. N Engl J Med, 2014, 370(1): 60-68.
2. Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010[J]. N Engl J Med, 2011, 364(25): 2469-2470.
3. Wilemse BW, Postma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation[J]. Eur Respir J, 2004, 23(3): 464-476.
4. Godtfredsen NS, Lam TH, Hansel TT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence[J]. Eur Respir J, 2008, 32(4): 844-853.
5. Garcia AJ, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study[J]. Am J Repsir Crit Care Med, 2007, 175(5): 458-463.
6. Fagerström KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment[J]. Ear Nose Throat J, 1990, 69(11): 763-768.
7. Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers[J]. Eur Respir J, 2009, 33(3): 509-518.
8. Mastrelli P, Saetta M, Mapp CE, et al. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease[J]. Am J Respir Crit Med, 2001, 164(10 Pt 2): S76-S80.
9. Azevedo RC, Fernandes RF. Factors relating to failure to quit smo-king: a prospective cohort study[J]. Sao Paulo Med J, 2011, 129(6): 380-386.
10. Henningfield JE. Nicotine medications for smoking cessation[J]. N Engl J Med, 1995, 333(18): 1196-1203.
11. Martín Cantera C, Puigdomènech E, Ballvé JL, et al. Effectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic review [J]. BMJ Open, 2015,5(10):e008807.
12. Dale LC, Ebbert JO, Hays JT, et al. Treatment of nicotine depen-dence[J]. Mayo Clin Proc, 2000, 75(12): 1311-1316.
13. Wang C, Cho B, Xiao D, et al. Effectiveness and safety of varenicline as an aid to smoking cessation: Results of an inter-Asian observational study in real-world clinical practice[J]. Int J Clin Pract, 2013, 67(5): 469-476.
14. Andreas S, Chenot JF, Diebold R, et al. Effectiveness and safety of varenicline as an aid to smoking cessation in primary care: an observational study[J]. Eur Addict Res, 2013, 19(1): 47-54.
15. Bhang SY, Choi SW, Ahn JH, et al. Predictors of success at six month follow-up at a public smoking cessation clinic in South Korea[J]. Asia Pac Psychiatry, 2013, 5(3): 197-204.
16. A clinical practice guideline for treating tobacco use and depen-dence: a US Public Health Service report. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives[J]. JAMA, 2000, 283(24): 3244-3254.
17. Han YW, Mohammad M, Liew SM. Effectiveness of a brief physician counseling session on improving smoking behavior in the Workplace[J]. Asian Pac J Cancer Prev, 2014, 15(17): 7287-7290.